Suppr超能文献

血糖控制不佳与 1 型糖尿病诊断后一年的骨量积累受损有关。

Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes.

机构信息

Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York.

The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4511-4520. doi: 10.1210/jc.2019-00035.

Abstract

CONTEXT

Type 1 diabetes (T1D) is associated with an increased fracture risk across the life course. The effects on bone accrual early in the disease are unknown.

OBJECTIVE

To characterize changes in bone density and structure over the year following diagnosis of T1D and to identify contributors to impaired bone accrual.

DESIGN

Prospective cohort study.

SETTING

Academic children's hospital.

PARTICIPANTS

Thirty-six children, ages 7 to 17 years, enrolled at diagnosis of T1D.

OUTCOMES

Whole body and regional dual-energy X-ray absorptiometry and tibia peripheral quantitative computed tomography obtained at baseline and 12 months. The primary outcome was bone accrual assessed by bone mineral content (BMC) and areal bone mineral density (aBMD) velocity z score.

RESULTS

Participants had low total body less head (TBLH) BMC (z = -0.46 ± 0.76), femoral neck aBMD (z = -0.57 ± 0.99), and tibia cortical volumetric BMD (z = -0.44 ± 1.11) at diagnosis, compared with reference data, P < 0.05. TBLH BMC velocity in the year following diagnosis was lower in participants with poor (hemoglobin A1c ≥7.5%) vs good (hemoglobin A1c <7.5%) glycemic control at 12 months, z = -0.36 ± 0.84 vs 0.58 ± 0.71, P = 0.003. TBLH BMC velocity was correlated with gains in tibia cortical area (R = 0.71, P = 0.003) and periosteal circumference (R = 0.67, P = 0.007) z scores in participants with good, but not poor control.

CONCLUSIONS

Our results suggest that the adverse effects of T1D on BMD develop early in the disease. Bone accrual following diagnosis was impaired in participants with poor glycemic control and appeared to be mediated by diminished bone formation on the periosteal surface.

摘要

背景

1 型糖尿病(T1D)与整个生命周期的骨折风险增加有关。疾病早期对骨积累的影响尚不清楚。

目的

描述 T1D 诊断后一年内骨密度和结构的变化,并确定导致骨积累受损的因素。

设计

前瞻性队列研究。

地点

学术儿童医院。

参与者

36 名年龄在 7 至 17 岁之间的儿童,在 T1D 诊断时入组。

结果

基线和 12 个月时获得全身和局部双能 X 射线吸收法和胫骨外周定量计算机断层扫描。主要结果是通过骨矿物质含量(BMC)和面积骨矿物质密度(aBMD)速度 z 评分评估的骨积累。

结果

与参考数据相比,参与者在诊断时的全身非头部(TBLH)BMC(z = -0.46 ± 0.76)、股骨颈 aBMD(z = -0.57 ± 0.99)和胫骨皮质体积 BMD(z = -0.44 ± 1.11)较低,P < 0.05。在 12 个月时,血糖控制良好(糖化血红蛋白<7.5%)的参与者与血糖控制不佳(糖化血红蛋白≥7.5%)的参与者相比,TBLH 骨矿物质密度在诊断后 1 年内的增长速度较低,z = -0.36 ± 0.84 与 0.58 ± 0.71,P = 0.003。在血糖控制良好的参与者中,TBLH BMC 速度与胫骨皮质面积(R = 0.71,P = 0.003)和骨膜周长(R = 0.67,P = 0.007)z 评分的增加相关,但在血糖控制不佳的参与者中则不然。

结论

我们的结果表明,T1D 对 BMD 的不利影响在疾病早期就出现了。血糖控制不佳的参与者在诊断后骨积累受损,这似乎是由于骨膜表面骨形成减少所致。

相似文献

6
Childhood type 1 diabetes is associated with abnormal bone development.儿童 1 型糖尿病与骨骼发育异常有关。
Pediatr Diabetes. 2022 Sep;23(6):773-782. doi: 10.1111/pedi.13367. Epub 2022 Jun 6.

引用本文的文献

2
Sclerostin as a new target of diabetes-induced osteoporosis.硬化蛋白作为糖尿病性骨质疏松症的新靶点。
Front Endocrinol (Lausanne). 2024 Dec 10;15:1491066. doi: 10.3389/fendo.2024.1491066. eCollection 2024.
6
Glycemic Control and Bone in Diabetes.血糖控制与糖尿病患者的骨骼健康
Curr Osteoporos Rep. 2022 Dec;20(6):379-388. doi: 10.1007/s11914-022-00747-6. Epub 2022 Oct 10.
9
Bone Health in Pediatric Patients with IBD: What Is New?炎症性肠病患儿的骨骼健康:有哪些新进展?
Curr Osteoporos Rep. 2021 Aug;19(4):429-435. doi: 10.1007/s11914-021-00691-x. Epub 2021 Jun 22.

本文引用的文献

5
12. Children and Adolescents: .12. 儿童和青少年: 。
Diabetes Care. 2018 Jan;41(Suppl 1):S126-S136. doi: 10.2337/dc18-S012.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验